Back to Authors

Niveloni, Sonia I.

Mayo Clinic

Hospital Dr. Carlos Nonorino Udaondo Buenos Aires Argentina

Citations 1

Creation of a model to predict survival in patients with refractory coeliac disease using a multinational registry
Malamut, Georgia , Verbeek, Wieke H.M. , Wanrooij, Roy L.J. van , Leffler, Daniel A. , Niveloni, Sonia I., Argüelles-Grande, Carolina , Lahr, Brian D. , Zinsmeister, Alan R., Kelly, Ciarán P. , Bai, Jie , Green, P. H., Daum, S , Mulder, Chris J. , Cellier, Christophe , Rubio‐Tapia, Alberto , Murray, Joseph A. , van Wanrooij, Roy L J , Malamut, Georgia

Alimentary Pharmacology & Therapeutics | August 3, 2016 | Volume: 44 | Issue: 7 | Pages: 704-714

10.1111/apt.13755 Get It

SummaryBackgroundRefractory coeliac disease is a severe complication of coeliac disease with heterogeneous outcome.AimTo create a prognostic model to estimate survival of patients with refractory coeliac disease.MethodsWe evaluated predictors of 5‐year mortality using Cox proportional hazards regression on subjects from a multinational registry. Bootstrap resampling was used to internally validate the individual factors and overall model performance. The mean of the estimated regression coefficients from 400 bootstrap models was used to derive a risk score for 5‐year mortality.ResultsThe multinational cohort was composed of 232 patients diagnosed with refractory coeliac disease across seven centres (range of 11–63 cases per centre). The median age was 53 years and 150 (64%) were women. A total of 51 subjects died during a 5‐year follow‐up (cumulative 5‐year all‐cause mortality = 30%). From a multiple variable Cox proportional hazards model, the following variables were significantly associated with 5‐year mortality: age at refractory coeliac disease diagnosis (per 20 year increase, hazard ratio = 2.21; 95% confidence interval, CI: 1.38–3.55), abnormal intraepithelial lymphocytes (hazard ratio = 2.85; 95% CI: 1.22–6.62), and albumin (per 0.5 unit increase, hazard ratio = 0.72; 95% CI: 0.61–0.85). A simple weighted three‐factor risk score was created to estimate 5‐year survival.ConclusionsUsing data from a multinational registry and previously reported risk factors, we create a prognostic model to predict 5‐year mortality among patients with refractory coeliac disease. This new model may help clinicians to guide treatment and follow‐up.